| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/19/2010 | US20100210734 Method of using calcitriol for treating intraocular diseases associated with angiogenesis |
| 08/19/2010 | US20100210727 Hepoxilin analog enantiomers |
| 08/19/2010 | US20100210720 Preservative-free prostaglandin-based ophthalmic solution |
| 08/19/2010 | US20100210697 Pharmaceutical composition for treatment of cataract |
| 08/19/2010 | US20100210689 Therapeutic substituted chlorocyclopentanols |
| 08/19/2010 | US20100210685 Novel Substituted Indoles |
| 08/19/2010 | US20100210641 Organic Compounds |
| 08/19/2010 | US20100210606 Methods and reagents for the treatment of inflammatory disorders |
| 08/19/2010 | US20100210572 Hydrolysate of crocin |
| 08/19/2010 | US20100210566 Azapeptides as cd36 binding compounds |
| 08/19/2010 | US20100210561 Use of peptide as a therapeutic agent |
| 08/19/2010 | US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/19/2010 | US20100210540 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 08/19/2010 | US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof |
| 08/19/2010 | US20100210532 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent |
| 08/19/2010 | US20100209539 Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye |
| 08/19/2010 | US20100209529 Pharmacologic-functioning water and usage of the same |
| 08/19/2010 | US20100209526 Product comprising a combination of milk serum apoproteins and free fatty acids |
| 08/19/2010 | US20100209513 Pharmaceutical composition containing micronized particles of naphthoquinone-based compound |
| 08/19/2010 | US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 08/19/2010 | US20100209506 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 08/19/2010 | US20100209478 Drug delivery through hydrogel plugs |
| 08/19/2010 | US20100209477 Sustained release delivery of one or more agents |
| 08/19/2010 | US20100209447 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| 08/19/2010 | US20100209411 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears |
| 08/19/2010 | US20100209384 Sustained release formulations comprising very low molecular weight polymers |
| 08/19/2010 | CA2751517A1 [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
| 08/19/2010 | CA2750242A1 Drug delivery through hydrogel plugs |
| 08/18/2010 | EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction |
| 08/18/2010 | EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/18/2010 | EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/18/2010 | EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/18/2010 | EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 08/18/2010 | EP2218446A1 Method for producing microcapsule using solid fat |
| 08/18/2010 | EP2218442A1 Methods, compositions, and kits for the treatment of ophthalmic disorders |
| 08/18/2010 | EP2217589A2 Modulators of ocular oxidative stress |
| 08/18/2010 | EP2217581A1 Substituted cyclopentanes having prostaglanding activity |
| 08/18/2010 | EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 08/18/2010 | EP1121115B2 Pufa supplements |
| 08/18/2010 | CN1704121B Anti-angiogenic compositions and methods of use |
| 08/18/2010 | CN101805688A Mulberry health-care wine and preparation method thereof |
| 08/18/2010 | CN101805391A Preparation method of sodium tanshinone IIA for injection |
| 08/18/2010 | CN101804174A Traditional Chinese medicine preparation for treating sicca syndrome |
| 08/18/2010 | CN101804091A Traditional Chinese medicine for treating catarrhal conjunctivitis and preparation method thereof |
| 08/18/2010 | CN101804078A Centipede oil for treating suppurative otitis media and preparation method thereof |
| 08/18/2010 | CN101804057A Chuagxiongzine ophthalmic preparation |
| 08/18/2010 | CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
| 08/18/2010 | CN101087613B Preventing or treating agent for glaucoma |
| 08/17/2010 | US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/17/2010 | US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/17/2010 | US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis |
| 08/17/2010 | US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 08/17/2010 | US7776898 Opioid receptor active compounds |
| 08/17/2010 | US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs |
| 08/17/2010 | CA2569691C Methods and compositions for treating ophthalmic conditions with retinyl derivatives |
| 08/17/2010 | CA2431974C Urea and urethane derivatives as integrin inhibitors |
| 08/17/2010 | CA2411436C A method for detecting protein inhibitors and ligands |
| 08/17/2010 | CA2408301C Methods of pre-selecting a polymerizable fluid formed into an intraocular lens |
| 08/17/2010 | CA2403086C Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
| 08/17/2010 | CA2384690C Rivastigmine for the treatment of ocular disorders |
| 08/17/2010 | CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 08/12/2010 | WO2010090299A1 A novel cyanopyrimidine derivative |
| 08/12/2010 | WO2010089355A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| 08/12/2010 | WO2010088827A1 Novel uses of huperzine a and ophthalmic preparations thereof |
| 08/12/2010 | WO2010046865A3 Ophthalmic administration of a composition including brimonidine as a mist |
| 08/12/2010 | WO2009137085A8 Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 08/12/2010 | WO2007019344A8 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 08/12/2010 | US20100204332 Method for treating a disease or condition responsive to opening of c1c-2 channel |
| 08/12/2010 | US20100204311 Normal-tension glaucoma model and method for evaluation of test substances by using same |
| 08/12/2010 | US20100204244 Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration |
| 08/12/2010 | US20100204227 Isoindoline compounds and methods of their use |
| 08/12/2010 | US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/12/2010 | US20100204208 Protein kinase c inhibitors and uses thereof |
| 08/12/2010 | US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/12/2010 | US20100204194 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 08/12/2010 | US20100204190 New combinations |
| 08/12/2010 | US20100204182 Ectonucleotidase inhibitors |
| 08/12/2010 | US20100204152 Use of gluten exorphin c : as a therapeutic agent |
| 08/12/2010 | US20100204137 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 08/12/2010 | US20100204124 Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members |
| 08/12/2010 | US20100204114 Use of a galanin peptide as a therapeutic agent |
| 08/12/2010 | US20100204110 Use of a peptide as a therapeutic agent |
| 08/12/2010 | US20100204086 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 08/12/2010 | US20100203542 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 08/12/2010 | US20100203169 Composition and Method of Treating Side Effects From Antibiotic Treatment |
| 08/12/2010 | US20100203165 Compositions and methods for treatment of disorders or conditions of the eye |
| 08/12/2010 | US20100203103 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues |
| 08/12/2010 | US20100203079 Ophthalmic composition containing xanthan gum and amino acid |
| 08/12/2010 | US20100203062 Methods and Compositions for Treatment of Neovascularization |
| 08/12/2010 | US20100203061 Prevention and treatment of retinal ischemia and edema |
| 08/12/2010 | US20100203041 Antibodies to egfl7 and methods for their use |
| 08/12/2010 | US20100203016 Pregnancy hormone combination for treatment of autoimmune diseases |
| 08/12/2010 | CA2751438A1 Methods and compositions for treatment of neovascularization |
| 08/12/2010 | CA2749358A1 A novel cyanopyrimidine derivative |
| 08/11/2010 | EP2216409A1 Albumin fusion proteins |
| 08/11/2010 | EP2216026A1 Ophthalmic compositions and uses for treating ophthalmic conditions |
| 08/11/2010 | EP2216019A2 Ophthalmic uses of S1P receptor modulators |
| 08/11/2010 | EP2215084A2 Therapeutic substituted lactams |
| 08/11/2010 | EP2214660A2 Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions |
| 08/11/2010 | EP2214482A1 Prostaglandin analog compositions and methods to treat epithelial-related conditions |